Filed with the SEC on · accession 0001140361-26-043308
GRCE filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Grace Therapeutics, Inc. furnished a Form 8-K under Item 2.02 announcing its financial results for the three months ended September 30, 2026, via an attached press release (Exhibit 99.1).
✦ Ask GOAX AI about this filing — what it means for GRCE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for GRCE?
Click hereGRCE filed a 8-K (SEC filing). Grace Therapeutics, Inc. furnished a Form 8-K under Item 2.02 announcing its financial results for the three months ended September 30, 2026, via an attached press release (Exhibit 99.1).
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Get alerts when GRCE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days